Breast Cancer Res. 2003;5(2):109-12. Epub 2003 Feb 5.

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research.

Source

Section of Medicine, Institute of Cancer Research, Sutton, UK. jhead@icr.ac.uk

Abstract

The Annual San Antonio Breast Cancer Symposium is one of the largest regular conferences devoted to breast cancer research and treatment. In particular, it provides a forum in which to discuss the more translational aspects of current basic research, and the 2002 meeting was no exception. Growth factor pathways and endocrine resistance, cancer genomics and the clinical applications of proteomics were three of the major topics for discussion. Presentations on genetic susceptibility and the development of prognostic and predictive markers also created much interest.

PMID:: 12631391; [PubMed - indexed for MEDLINE]
PMCID: PMC154153

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Congresses

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research. [Breast Cancer Res. 2004]
26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.
Lee AV, Chamness G, Oesterreich S. Breast Cancer Res. 2004 Jan 19; 6(2):E10. Epub 2004 Jan 19.
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research. [Breast Cancer Res. 2003]
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research.
Ring A, Head J. Breast Cancer Res. 2003; 5(2):113-6. Epub 2003 Feb 5.
Selected highlights from the 26th San Antonio Breast Cancer Symposium. December 3-6, 2003, San Antonio, TX, USA. [Expert Opin Pharmacother. 2004]
Selected highlights from the 26th San Antonio Breast Cancer Symposium. December 3-6, 2003, San Antonio, TX, USA.
Montemurro F, Aglietta M. Expert Opin Pharmacother. 2004 Apr; 5(4):981-9.
Review Clinically relevant biology of hereditary breast cancer. [Semin Oncol. 2007]
Review Clinically relevant biology of hereditary breast cancer.
Foulkes WD. Semin Oncol. 2007 Oct; 34(5):379-83.
Review BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families. [Fam Cancer. 2006]
Review BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM. Fam Cancer. 2006; 5(1):15-20.

See reviews... See all...

Cited by 1 PubMed Central article

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research. [Breast Cancer Res. 2003]
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research.
Ring A, Head J. Breast Cancer Res. 2003; 5(2):113-6. Epub 2003 Feb 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 ...
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research.
Breast Cancer Res. 2003 ;5(2):109-12. Epub 2003 Feb 5 .

PubMed
Reduction in bone relapse and improved survival with oral clodronate for adjuvan...
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Breast Cancer Res. 2006 ;8(2):R13. Epub 2006 Mar 15 .

PubMed
Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at t...
Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
Proc Natl Acad Sci U S A. 2004 Dec 21 ;101(51):17705-10. Epub 2004 Dec 10 .

PubMed
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopau...
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.
J Clin Oncol. 2002 Aug 15 ;20(16):3396-403.

PubMed
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog e...
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.
Nat Cell Biol. 2005 Feb ;7(2):165-71. Epub 2004 Dec 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information